These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7183486)

  • 21. Carbenoxolone maintenance in cimetidine-healed patients.
    Guslandi M; Cambielli M; Tittobello A
    Scand J Gastroenterol; 1980; 15(3):369-71. PubMed ID: 7433897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experiences with a cimetidine depot preparation (Neutronorm retard) in the treatment of peptic ulcer].
    Pesendorfer FX; Salocher C
    Wien Med Wochenschr; 1983; 133(4-5):123-4, 126. PubMed ID: 6344445
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of the combinations atropine + cyproheptadine and atropine + carbenoxolone in duodenal ulcer therapy.
    Tárnok F; Deák G; Jávor T; Mózsik G; Nagy L; Patty I
    Int J Tissue React; 1983; 5(3):315-21. PubMed ID: 6654627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duodenal mycosis during carbenoxolone and cimetidine treatment.
    Lombardo L; Pera A; Genovesio L; Verme G
    Lancet; 1979 Mar; 1(8116):607-8. PubMed ID: 85187
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of cimetidine and carbenoxolone on cysteamine-induced ulcers: a study of gastric mucosal histamine and histamine formation capacity in rat.
    Man WK; Boesby S; Mendez-Diaz R; Spencer J
    Agents Actions; 1984 Dec; 15(5-6):467-73. PubMed ID: 6532172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perforation of gastric carcinoma (at site of previous benign ulcer) after withdrawal of cimetidine.
    Buck JP; Murgatroyd RE; Boylston AW; Baron JH
    Lancet; 1979 Jul; 2(8132):42. PubMed ID: 87920
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the neutralizing activity on gastric acidity of a carbenoxolone-antacid formulation using computerized gastric pH-metry in healthy volunteers].
    Passaretti S; Tittobello A
    Clin Ter; 1988 Mar; 124(5):357-61. PubMed ID: 2974345
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anti-secretory therapy of peptic ulcer with cimetidine and activation of the mucosal barrier with zolimidine: preliminary results of combined treatment].
    Assisi R; De Miranda B; De Stefano S
    Clin Ter; 1980 Jun; 93(5):563-75. PubMed ID: 6448726
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term therapy with carbenoxolone in the prevention of recurrence of gastric ulcer. Natural history and evolution of important side-effects and measures to avoid them.
    Ganguli PC; Mohamed SD
    Scand J Gastroenterol Suppl; 1980; 65():63-71. PubMed ID: 6937941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs for peptic ulcer.
    Jones FA; Hunt T
    World J Surg; 1979 Sep; 3(5):659-60. PubMed ID: 516781
    [No Abstract]   [Full Text] [Related]  

  • 32. Histochemistry of the gastric and duodenal mucosa under cimetidine and carbenoxolone treatment.
    Lojda Z; Maratka Z
    Scand J Gastroenterol Suppl; 1989; 167():13-5. PubMed ID: 2617161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of enprostil and cimetidine is more effective than cimetidine alone in treating gastric ulcer: prospective multicenter randomized controlled trial.
    Murata H; Kawano S; Tsuji S; Tsujii M; Hori M; Kamada T; Matsuzawa Y; Katsu K; Inoue K; Kobayashi K; Mitsufuji S; Bamba T; Kawasaki H; Kajiyama G; Umegaki E; Inoue M; Saito I
    Hepatogastroenterology; 2005; 52(66):1925-9. PubMed ID: 16334808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of peptic ulcer with cytoprotective substances].
    Fortunat W
    Wien Med Wochenschr; 1983; 133(4-5):94-8. PubMed ID: 6407215
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of recurrent aphthous ulcers. A trial of carbenoxolone sodium mouthwash.
    Poswillo D; Partridge M
    Br Dent J; 1984 Jul; 157(2):55-7. PubMed ID: 6588992
    [No Abstract]   [Full Text] [Related]  

  • 36. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone-marrow depression with cimetidine plus carmustine.
    Selker RG; Moore P; Lodolce D
    N Engl J Med; 1978 Oct; 299(15):834. PubMed ID: 692572
    [No Abstract]   [Full Text] [Related]  

  • 38. Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium.
    Guslandi M
    Acta Gastroenterol Belg; 1983; 46(9-10):411-8. PubMed ID: 6673456
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of carbenoxolone on prostaglandin synthesizing and metabolizing enzymes and correlation with gastric mucosal carbenoxolone concentrations.
    Peskar BM
    Scand J Gastroenterol Suppl; 1980; 65():109-14. PubMed ID: 6259713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of a metoclopramide-carbenoxolone combination in duodenal reflux pathology].
    Procacciante F; Pronio A; Perri S; Catani M; Montesani C; Citone G; Ribotta G
    Minerva Chir; 1987 Oct; 42(19):1487-90. PubMed ID: 3683907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.